Caesalmin BCAS# 352658-23-2 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 352658-23-2 | SDF | Download SDF |
| PubChem ID | 12037261 | Appearance | Powder |
| Formula | C22H28O6 | M.Wt | 388.46 |
| Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CC(=O)OC1CCC(C2(C1(C3CC4=C(C=CO4)C5C3C(C2)OC5=O)C)O)(C)C | ||
| Standard InChIKey | GXBMHMVGIRRPBD-XTVZKPICSA-N | ||
| Standard InChI | InChI=1S/C22H28O6/c1-11(23)27-16-5-7-20(2,3)22(25)10-15-18-13(21(16,22)4)9-14-12(6-8-26-14)17(18)19(24)28-15/h6,8,13,15-18,25H,5,7,9-10H2,1-4H3/t13-,15-,16-,17+,18-,21-,22+/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Caesalmin B shows significant dose-dependent inhibitory effects on Plasmodium falciparum FCR-3/A2 growth in vitro. |
| Targets | Antifection |
Caesalmin B Dilution Calculator
Caesalmin B Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.5743 mL | 12.8713 mL | 25.7427 mL | 51.4854 mL | 64.3567 mL |
| 5 mM | 0.5149 mL | 2.5743 mL | 5.1485 mL | 10.2971 mL | 12.8713 mL |
| 10 mM | 0.2574 mL | 1.2871 mL | 2.5743 mL | 5.1485 mL | 6.4357 mL |
| 50 mM | 0.0515 mL | 0.2574 mL | 0.5149 mL | 1.0297 mL | 1.2871 mL |
| 100 mM | 0.0257 mL | 0.1287 mL | 0.2574 mL | 0.5149 mL | 0.6436 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Delafloxacin meglumine
Catalog No.:BCC1523
CAS No.:352458-37-8
- 9-Methoxy-alpha-lapachone
Catalog No.:BCN5289
CAS No.:35241-80-6
- Benzoin methyl ether
Catalog No.:BCC8857
CAS No.:3524-62-7
- 4-(Bromomethyl)-7-methoxy coumarin
Catalog No.:BCC9202
CAS No.:35231-44-8
- Alloisoimperatorin
Catalog No.:BCN6789
CAS No.:35214-83-6
- Neobyakangelicol
Catalog No.:BCN5288
CAS No.:35214-82-5
- Ipriflavone (Osteofix)
Catalog No.:BCC5323
CAS No.:35212-22-7
- 4,5-Dimethoxy-1-cyanobenzocyclobutane
Catalog No.:BCC8665
CAS No.:35202-54-1
- AY-NH2
Catalog No.:BCC3949
CAS No.:352017-71-1
- JC-1
Catalog No.:BCC1669
CAS No.:3520-43-2
- D-Tetrahydropalmatine
Catalog No.:BCN2334
CAS No.:3520-14-7
- INCA-6
Catalog No.:BCC2462
CAS No.:3519-82-2
- 1-Chloroindan
Catalog No.:BCN2244
CAS No.:35275-62-8
- Ziyuglycoside I
Catalog No.:BCN5290
CAS No.:35286-58-9
- Ziyuglycoside II
Catalog No.:BCN5291
CAS No.:35286-59-0
- (E)-3-Hydroxy-5-methoxystilbene
Catalog No.:BCN5292
CAS No.:35302-70-6
- D-Alaninol
Catalog No.:BCC2728
CAS No.:35320-23-1
- LY 487379 hydrochloride
Catalog No.:BCC7627
CAS No.:353229-59-1
- NS 6180
Catalog No.:BCC6307
CAS No.:353262-04-1
- S26948
Catalog No.:BCC7751
CAS No.:353280-43-0
- Monocrotaline N-oxide
Catalog No.:BCN2097
CAS No.:35337-98-5
- TQS
Catalog No.:BCC7896
CAS No.:353483-92-8
- 9-Hydroxycalabaxanthone
Catalog No.:BCN5293
CAS No.:35349-68-9
- HLM006474
Catalog No.:BCC5403
CAS No.:353519-63-8
Cassane- and norcassane-type diterpenes from Caesalpinia crista of Indonesia and their antimalarial activity against the growth of Plasmodium falciparum.[Pubmed:15921414]
J Nat Prod. 2005 May;68(5):706-10.
The CH2Cl2 extract of the seed kernels of Caesalpinia crista, which exhibited promising antimalarial activity against Plasmodium berghei-infected mice in vivo, was examined and resulted in the isolation of seven new furanocassane-type diterpenes [caesalpinins C-G (1-5) and norcaesalpinins D and E (6, 7)] together with norcaesalpinins A-C (8-10) and 11 known compounds (norcaesalpinins A-C, 2-acetoxy-3-deacetoxycaesaldekarin e, Caesalmin B, caesaldekarin e, caesalpin F, 14(17)-dehydrocaesalpin F, 2-acetoxycaesaldekarin e, 7-acetoxybonducellpin C, and caesalmin G). Their structures were determined on the basis of spectroscopic analysis. The isolated diterpenes showed significant dose-dependent inhibitory effects on Plasmodium falciparum FCR-3/A2 growth in vitro. Their IC50 values ranged from 90 nM to 6.5 microM, and norcaesalpinin E (7) showed the most potent inhibitory activity (IC50, 90 nM).
Cassane- and norcassane-type diterpenes of Caesalpinia crista from Myanmar.[Pubmed:15568776]
J Nat Prod. 2004 Nov;67(11):1859-63.
From the CH(2)Cl(2) extract of seed kernels of Caesalpinia crista from Myanmar, five new cassane-type diterpenes, caesalpinins MA-ME (1-5), and three new norcassane-type diterpenes, norcaesalpinins MA-MC (6-8), have been isolated, together with 12 known cassane-type diterpenes, 14(17)-dehydrocaesalmin F, caesaldekarin e, Caesalmin B, caesalmin C, caesalmin E, 2-acetoxy-3-deacetoxycaesaldekarin e, 2-acetoxycaesaldekarin e, caesalpinin C, 7-acetoxybonducellpin C, caesalpinin E, norcaesalpinin B, and 6-acetoxy-3-deacetoxycaesaldekarin e. The structures of the isolated compounds were elucidated by analysis of their spectroscopic data.
Molecular structures and antiviral activities of naturally occurring and modified cassane furanoditerpenoids and friedelane triterpenoids from Caesalpinia minax.[Pubmed:11983512]
Bioorg Med Chem. 2002 Jul;10(7):2161-70.
Further investigation of the active components of the chloroform fraction of the seeds of Caesalpinia minax led to the isolation of a new cassane furanoditerpenoid, caesalmin H (1), together with two known furanoditerpenoid lactones, Caesalmin B (2) and bonducellpin D (3). Reduction of the naturally abundant caesalmin D (9), E (10) and F (11) resulted in three new furanoditerpenoid derivatives 4-6. Phytochemical study of the stem of the same plant and subsequent reduction afforded two friedelane triterpenoids (7-8), which were identified by spectroscopic methods. Compounds 1-2 and 4-8 were corroborated by single crystal X-ray analysis. The factors governing the reduction of cassane furanoditerpenoids and friedelane triterpenoids were investigated by correlating the crystallographic results with density functional theory. The inhibitory activities of 2-8 on the Para3 virus were evaluated by cytopathogenic effects (CPE) reduction assay.
